Tag: global mrna therapeutics market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The mRNA Cancer Vaccines And Therapeutics Market Over The 2026–2030 Period?

The mrna cancer vaccines and therapeutics market size has expanded rapidly in recent years. It is forecast to increase from $71.22 billion in 2025 to $82.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.1%. This historical growth can be linked to the successful deployment of mrna platforms in infectious disease vaccines, progress in cancer immunology research, a better understanding of tumor antigens, early clinical validation of mrna cancer therapies, and rising public and private funding for oncology innovation.

The mrna cancer vaccines and therapeutics market is anticipated to experience substantial growth over the coming years. It is forecast to achieve a valuation of $141.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. This projected expansion during the forecast period is driven by the increasing global incidence of cancer, the rising demand for customized and targeted cancer treatments, an enlargement of mrna manufacturing capabilities, a growing number of oncology clinical trials employing mrna platforms, and strategic partnerships between biotech and pharmaceutical enterprises. Significant trends for the forecast period encompass the increasing acceptance of personalized cancer vaccines, the extension of mrna-based therapeutics into applications beyond oncology, an intensified focus on the development of neoantigen-specific vaccines, an expanding clinical pipeline for mrna cancer immunotherapies, and greater investment in scalable mrna manufacturing platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

What Drivers Are Expected To Influence The mRNA Cancer Vaccines And Therapeutics Market During The Forecast Period?

The increasing occurrence of cancer is projected to stimulate the expansion of the mRNA cancer vaccine and therapeutic market in the future. Cancer encompasses a range of illnesses marked by the unregulated proliferation and dispersion of atypical cells, which can infiltrate and harm healthy tissues. The growing frequency of cancer is primarily linked to elements like inactive lifestyles, inadequate nutritional practices, and exposure to ecological poisons, all contributing to an elevated risk of diverse cancers. mRNA cancer vaccines and therapeutics are vital for enhancing cancer treatment, facilitating tailored, precise immune reactions that aid the body in more efficiently recognizing and eradicating cancer cells, consequently bettering treatment results. As an illustration, in January 2024, the American Cancer Society, Inc., a US-based cancer advocacy organization, projected that the United States would see over 611,000 cancer-related deaths in 2024, averaging more than 1,600 fatalities per day. Consequently, the increasing prevalence of cancer is fueling the expansion of the mRNA cancer vaccine and therapeutic market.

How Is The mRNA Cancer Vaccines And Therapeutics Market Segmented Across Key Categories?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Which Upcoming Trends Are Expected To Influence The mRNA Cancer Vaccines And Therapeutics Market?

Leading firms within the mRNA cancer vaccines and therapeutics market are concentrating on creating cutting-edge solutions, including personalized neoantigen vaccines, with the goal of boosting immune responses and increasing survival rates for cancer patients. These personalized neoantigen vaccines represent cancer treatments custom-built for individual patients, leveraging distinct tumor-specific mutations to prompt the immune system to identify and eliminate cancerous cells. An example of this is the collaboration formed in July 2023 between Merck & Co., Inc., a US-based biopharmaceutical firm focused on research, and Moderna Therapeutics, Inc., a US-based biotechnology enterprise. They commenced a randomized Phase 3 clinical trial, designated V940-001, which aims to assess mRNA-4157 (V940) combined with KEYTRUDA (pembrolizumab) for use as an adjuvant therapy in individuals with resected high-risk (Stage IIB-IV) melanoma. This trial proceeds after promising outcomes from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, where the combination demonstrated a significant advantage compared to KEYTRUDA by itself in lowering the risk of recurrence and distant metastasis. The objective of the Phase 3 trial is to corroborate these prior results by measuring relapse-free survival and distant metastasis-free survival as its primary and secondary endpoints, in that order.

Who Are The Dominant Players Shaping The mRNA Cancer Vaccines And Therapeutics Market Landscape?

Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)

Read the full mrna cancer vaccines and therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Region Is Forecast To Lead The mRNA Cancer Vaccines And Therapeutics Market In Terms Of Market Size?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored mRNA Cancer Vaccines And Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2026, By The Business Research Company

Mrna Cancer Vaccines And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Mrna Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the mrna cancer vaccines and therapeutics market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the mRNA Cancer Vaccines And Therapeutics Market between 2026 and 2030?

The mrna cancer vaccines and therapeutics market has expanded considerably in recent years. It is projected to increase from $71.22 billion in 2025 to $82.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.1%. This historic growth is largely attributable to the success of mrna platforms in infectious disease vaccines, ongoing advancements in cancer immunology research, an improved understanding of tumor antigens, early clinical validation of mrna cancer therapies, and increasing public and private funding directed towards oncology innovation.

The mrna cancer vaccines and therapeutics market is anticipated to experience significant expansion over the next few years, with projections indicating a rise to $141.51 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.4%. This projected growth stems from several factors, including the increasing global prevalence of cancer, the escalating demand for tailored and precise cancer treatments, the expansion of mrna manufacturing capabilities, a rise in oncology clinical trials utilizing mrna platforms, and strategic partnerships between biotech and pharmaceutical companies. Key developments expected during this period involve the increasing embrace of personalized cancer vaccines, the broadening application of mrna-based therapeutics beyond oncology, an intensified focus on developing neoantigen-specific vaccines, a growing clinical pipeline for mrna cancer immunotherapies, and greater investment in scalable mrna manufacturing platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The mRNA Cancer Vaccines And Therapeutics Market?

The expanding incidence of cancer is projected to stimulate expansion within the mRNA cancer vaccine and therapeutic market moving forward. Cancer itself encompasses a range of illnesses marked by the unregulated proliferation and dissemination of abnormal cells, capable of infiltrating and harming healthy tissues. This escalating occurrence of cancer is primarily linked to elements such as inactive lifestyles, inadequate nutritional practices, and exposure to environmental pollutants, all contributing to an elevated risk of various cancers. mRNA cancer vaccines and therapeutics are vital for enhancing cancer treatment, facilitating tailored, precise immune reactions that aid the body in identifying and eradicating cancerous cells more proficiently, thereby improving patient results. For example, in January 2024, data from the American Cancer Society, Inc., a US-based cancer advocacy organization, indicated that the United States is anticipated to record more than 611,000 cancer-related deaths in 2024, which translates to over 1,600 fatalities daily. Consequently, the increasing burden of cancer is propelling the demand in the mRNA cancer vaccine and therapeutic market.

What Segments Are Included Within The mRNA Cancer Vaccines And Therapeutics Market?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Which Trends Are Influencing The Development Of The mRNA Cancer Vaccines And Therapeutics Market?

Leading entities within the mRNA cancer vaccines and therapeutics market are concentrating on creating advanced approaches, including personalized neoantigen vaccines, to boost immune reactions and better survival rates for individuals with cancer. These personalized neoantigen vaccines represent cancer treatments tailored for individual patients, leveraging distinct mutations specific to their tumors to prompt the immune system into identifying and eradicating cancerous cells. An example of this strategy is the collaboration formed in July 2023 between Merck & Co., Inc., a US-based research-focused biopharmaceutical firm, and Moderna Therapeutics, Inc., a US-based biotechnology company. This partnership aims to commence a Phase 3 randomized clinical trial, designated V940-001, to assess mRNA-4157 (V940) when administered alongside KEYTRUDA (pembrolizumab) as an adjuvant therapy for individuals suffering from resected high-risk (Stage IIB-IV) melanoma. The initiation of this study comes after encouraging outcomes from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, where the combination demonstrated a significant advantage compared to KEYTRUDA used on its own, by lowering the risks of recurrence and distant metastasis. The objective of the Phase 3 trial is to corroborate these prior findings, with relapse-free survival serving as the primary endpoint and distant metastasis-free survival as the secondary endpoint for evaluation.

Who Are The Top-Performing Companies In The mRNA Cancer Vaccines And Therapeutics Market In Recent Years?

Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Region Currently Holds The Largest Share Of The mRNA Cancer Vaccines And Therapeutics Market?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized mRNA Cancer Vaccines And Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2026, By The Business Research Company

Mrna Cancer Vaccines And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Mrna Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the vaccine adjuvants market from 2025–2034 with trusted insights from The Business Research Company

How Is The Vaccine Adjuvants Market Size Expected To Expand Over 2029-2034?

The mRNA cancer vaccines and therapeutics market has expanded considerably in recent years. Its valuation is predicted to rise from $61.52 billion in 2024 to $71.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.8%. The expansion observed historically is a result of evolving lifestyles, financial assistance, a supportive regulatory framework, established healthcare systems, and increasing efforts in pipeline development.

The mRNA cancer vaccines and therapeutics market size is anticipated to experience swift expansion over the coming years. It is projected to reach $125.56 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.2%. This expected growth during the forecast period stems from factors such as promising clinical trial outcomes, increasing understanding and adoption of mRNA technology, existing unmet medical demands in cancer therapy, the possibility of enhanced patient results, and the prospect of readily available, off-the-shelf solutions. Key developments anticipated in the forecast period encompass broadening into new therapeutic domains, the adoption of a personalized medicine strategy, advancements in mRNA delivery mechanisms, the emergence of multivalent mRNA Vaccines, and the application of artificial intelligence and machine learning in mRNA design.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

Which Market Factors Are Fueling The Vaccine Adjuvants Industry Growth?

An anticipated increase in cancer cases is projected to drive the expansion of the mRNA cancer vaccine and therapeutic market. Cancer encompasses various diseases marked by the unchecked proliferation and dissemination of atypical cells, which infiltrate and damage healthy tissues. This uptick in cancer prevalence stems from factors such as inactive lifestyles, poor dietary choices, and exposure to harmful environmental substances. mRNA cancer vaccines and therapeutics are crucial in combating cancer as they provide tailored, specific therapies capable of boosting the immune system’s capacity to identify and combat malignant cells, thereby boosting treatment effectiveness and patient recovery. For example, the American Cancer Society, a US-based non-profit organization dedicated to eradicating cancer, reported in January 2023 that new cancer diagnoses in the United States were estimated at 1,918,030 in 2022, rising to 1,958,310 in 2023. Breast cancer remains the most prevalent chronic condition in the United States, with cases climbing from 287,850 in 2022 to 297,790 in 2023. Consequently, the growing incidence of cancer is propelling the expansion of the mRNA cancer vaccine and therapeutics market.

Which Categories Are Covered In The Vaccine Adjuvants Market Segmentation Analysis?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Infectious Disease, Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Which Market Trends Are Expected To Define The Future Of The Vaccine Adjuvants Market?

Leading companies within the mRNA cancer vaccine and therapeutics market are concentrating on developing innovative treatments, like mRNA cancer vaccines, to improve effectiveness, enhance patient results, and fulfill the rising need for successful cancer therapies. mRNA cancer vaccines function as a type of immunotherapy, employing messenger RNA to instruct cells to generate specific antigens, which in turn prompts the immune system to identify and target cancer cells. For example, in May 2024, WestGene Biopharma, a biotechnology company based in China, obtained FDA approval for an investigational new drug application for its mRNA therapeutic cancer vaccine, WGc-043. The FDA’s authorization of WGc-043 represents a significant stride in addressing advanced EB virus-related cancers, which are strongly associated with more than ten malignancies, including nasopharyngeal carcinoma, NK T-cell lymphoma, as well as gastric, lung, liver, esophageal, breast, and cervical cancers, in addition to autoimmune conditions such as multiple sclerosis and lupus.

Which Organizations Are At The Forefront Of The Vaccine Adjuvants Market?

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Vaccine Adjuvants Market?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Browse Through More Reports Similar to the Global Vaccine Adjuvants Market 2025, By The Business Research Company

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The mRNA Cancer Vaccines And Therapeutics Industry Compare Between 2025 And 2029?

The mRNA cancer vaccines and therapeutics market has seen rapid expansion in recent years. This market is expected to expand from $61.52 billion in 2024 to $71.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. The historical increase can be ascribed to evolving lifestyles, robust funding support, a conducive regulatory framework, an established healthcare infrastructure, and a rise in pipeline development.

The market for mRNA cancer vaccines and therapeutics is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $125.56 billion by 2029, achieving a compound annual growth rate (CAGR) of 15.2%. The increase during the forecast period stems from factors such as encouraging clinical trial outcomes, increasing understanding and adoption of mRNA technology, existing unmet medical demands in cancer therapy, the promise of better patient results, and the possibility of readily available, off-the-shelf products. Significant trends expected in this period encompass broadening into novel therapeutic domains, adopting a personalized medicine strategy, innovations in mRNA delivery mechanisms, the development of multivalent mRNA vaccines, and the integration of artificial intelligence and machine learning into mRNA design processes.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

Which Factors And Drivers Are Influencing The mRNA Cancer Vaccines And Therapeutics Market In 2025?

The increasing incidence of cancer is projected to stimulate expansion in the mRNA cancer vaccine and therapeutic market in the future. Cancer broadly refers to a collection of illnesses marked by the uncontrolled multiplication and dissemination of atypical cells, which infiltrate and harm healthy bodily tissue. This increase in cancer prevalence stems from inactive lifestyles, poor dietary choices, and exposure to environmental pollutants. mRNA cancer vaccines and therapies are essential for cancer as they provide customized, precise treatments capable of bolstering the immune system’s capacity to identify and combat cancer cells, thereby boosting treatment effectiveness and patient results. For example, data released in January 2023 by the American Cancer Society, a US-based non-profit dedicated to eradicating cancer, indicated that the estimated new cancer cases in the United States were approximately 1,918,030 in 2022, rising to 1,958,310 in 2023. Breast cancer stands as the primary chronic ailment in the United States, with cases growing from 287,850 in 2022 to 297,790 in 2023. Consequently, the escalating prevalence of cancer is a key factor propelling the expansion of the mRNA cancer vaccine and therapeutics market.

What Are The Key Segments In The mRNA Cancer Vaccines And Therapeutics Market?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Infectious Disease, Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

What Trends Are Expected To Drive The mRNA Cancer Vaccines And Therapeutics Market?

Prominent entities within the mRNA cancer vaccine and therapeutics market are prioritizing the creation of advanced therapies, specifically mRNA cancer vaccines, aiming to boost effectiveness, better patient results, and cater to the rising need for successful cancer treatments. mRNA cancer vaccines function as a form of immunotherapy leveraging messenger RNA to direct cells in producing target antigens, consequently prompting the immune system to identify and target malignant cells. For instance, in May 2024, WestGene Biopharma, a China-based biotechnology firm, secured FDA clearance for an investigational new drug application concerning its mRNA therapeutic cancer vaccine, WGc-043. The FDA’s approval of WGc-043 signifies a significant breakthrough in managing advanced EB virus-related cancers, which are closely associated with more than ten distinct malignancies, encompassing nasopharyngeal carcinoma, NK T-cell lymphoma, and gastric, lung, liver, esophageal, breast, and cervical cancers, as well as autoimmune conditions such as multiple sclerosis and lupus.

Which Industry Leaders Are Driving Innovation Across The mRNA Cancer Vaccines And Therapeutics Market?

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The mRNA Cancer Vaccines And Therapeutics Market?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The mRNA Cancer Vaccines And Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2025, By The Business Research Company

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The mRNA Cancer Vaccines And Therapeutics Industry By 2029?

In recent times, there has been a swift expansion in the market size for mRNA cancer vaccines and therapeutics. The market, which is projected to escalate from $61.52 billion in 2024 to $71.22 billion in 2025, will witness a compound annual growth rate (CAGR) of 15.8%. Factors that have contributed to this growth during the historic period include changing lifestyles, supportive funding, a propitious regulatory framework, a robust healthcare setup, and increased pipeline development.

Over the next several years, the mRNA cancer vaccines and therapeutics market is anticipated to undergo swift expansion. Projected to reach a value of $125.56 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%, this growth can largely be connected to factors such as positive clinical trial outcomes, increasing knowledge and acceptance of mRNA technology, unsatisfied needs in cancer care, the potential to enhance patient results and the possibility of off-the-shelf availability. Primary influential trends during the forecast period encompass broadening into new therapeutic domains, personalizing medical treatment, advancing mRNA delivery systems, multivalent mRNA vaccines and application of artificial intelligence and machine learning in mRNA design.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

Which Factors Are Steering Growth In The mRNA Cancer Vaccines And Therapeutics Market?

The escalating occurrence of cancer is predicted to stimulate expansion in the mRNA cancer vaccine and therapeutic market. Cancer refers to a range of diseases marked by uncontrolled growth and spread of abnormal cells that harm and kill normal bodily tissues. This rising trend of cancer can be attributed to inactive lifestyles, poor dietary choices, and exposure to environmental pollutants. mRNA cancer vaccines and treatments are critical in cancer management as they provide individualized, focused interventions that enhance the immune system’s capabilities to detect and combat cancerous cells, thereby improving the success rate of treatments and patient prognosis. For example, data from the American Cancer Society, a non-profit organization committed to eradicating cancer, showed that the projected number of newly diagnosed cancer cases in the United States rose from approximately 1,918,030 in 2022 to 1,958,310 in 2023. With breast cancer incidence leading the chronic conditions in the United States, the number of cases surged from 287,850 in 2022 to 297,790 in 2023. Hence, the increasing incidence of cancer is fueling the expansion of the mRNA cancer vaccine and therapeutics market.

What Are The Primary Segmentation Parameters In The mRNA Cancer Vaccines And Therapeutics Market?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Infectious Disease, Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Which Emerging Trends Are Reshaping The mRNA Cancer Vaccines And Therapeutics Market Landscape?

The mRNA cancer vaccine and therapeutics market is dominated by major industry players who are concentrating on developing innovative solutions like mRNA cancer vaccines to increase effectiveness, improve patient prognosis and meet the escalating need for potent cancer treatments. mRNA cancer vaccines belong to the immunotherapy category, utilizing messenger RNA to direct cells to create specific antigens, which boosts the immune system to identify and combat cancer cells. For instance, in May 2024, a biotech company from China, WestGene Biopharma, received FDA approval for a new investigational drug application of its mRNA cancer therapeutic vaccine, WGc-043. This approval by the FDA of WGc-043 represents a significant stride in dealing with advanced EB virus-associated cancers, closely connected to more than ten types of cancer, including nasopharyngeal carcinoma, NK T-cell lymphoma, and cancers of the stomach, lung, liver, esophagus, breast, and cervix, as well as autoimmune disorders like multiple sclerosis and lupus.

Which Organizations Are At The Forefront Of The mRNA Cancer Vaccines And Therapeutics Market?

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Region Holds The Greatest Opportunity For mRNA Cancer Vaccines And Therapeutics Market Expansion?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model